Breaking News

Actylis Opens API Manufacturing Facility

30,000 sq. ft. facility focuses on the manufacture of innovative APIs and excipients at both clinical trial and full commercial scale.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Actylis, a global manufacturer of raw materials and performance ingredients for the life sciences and specialty chemicals markets, has opened a new 30,000 square foot cGMP facility in Eugene, OR. The multi-million dollar construction commenced in February of 2021 and was completed in September of 2022, with commissioning and qualification completed at the end of January 2023. “Today we are delighted to announce that this purpose-built 30,000 square foot facility has commenced operations, allo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters